Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 156

Similar articles for PubMed (Select 21715555)


Uncoupling of proliferation and cytokines from suppression within the CD4+CD25+Foxp3+ T-cell compartment in the 1st year of human type 1 diabetes.

Hughson A, Bromberg I, Johnson B, Quataert S, Jospe N, Fowell DJ.

Diabetes. 2011 Aug;60(8):2125-33. doi: 10.2337/db10-1661. Epub 2011 Jun 29.


Defects in IL-2R signaling contribute to diminished maintenance of FOXP3 expression in CD4(+)CD25(+) regulatory T-cells of type 1 diabetic subjects.

Long SA, Cerosaletti K, Bollyky PL, Tatum M, Shilling H, Zhang S, Zhang ZY, Pihoker C, Sanda S, Greenbaum C, Buckner JH.

Diabetes. 2010 Feb;59(2):407-15. doi: 10.2337/db09-0694. Epub 2009 Oct 29.


At-risk and recent-onset type 1 diabetic subjects have increased apoptosis in the CD4+CD25+ T-cell fraction.

Glisic-Milosavljevic S, Waukau J, Jailwala P, Jana S, Khoo HJ, Albertz H, Woodliff J, Koppen M, Alemzadeh R, Hagopian W, Ghosh S.

PLoS One. 2007 Jan 3;2(1):e146.


Expression and functional characterization of FOXP3+ CD4+ regulatory T cells in ulcerative colitis.

Yu QT, Saruta M, Avanesyan A, Fleshner PR, Banham AH, Papadakis KA.

Inflamm Bowel Dis. 2007 Feb;13(2):191-9.


Reduced circulating CD4+CD25+ cell populations in haemorrhagic fever with renal syndrome.

Zhu LY, Chi LJ, Wang X, Zhou H.

Clin Exp Immunol. 2009 Apr;156(1):88-96. doi: 10.1111/j.1365-2249.2008.03858.x. Epub 2008 Dec 11.


Stimulation of α7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro.

Wang DW, Zhou RB, Yao YM, Zhu XM, Yin YM, Zhao GJ, Dong N, Sheng ZY.

J Pharmacol Exp Ther. 2010 Dec;335(3):553-61. doi: 10.1124/jpet.110.169961. Epub 2010 Sep 15.


Dysfunction of CD4+CD25high T regulatory cells in patients with recurrent aphthous stomatitis.

Lewkowicz N, Lewkowicz P, Dzitko K, Kur B, Tarkowski M, Kurnatowska A, Tchórzewski H.

J Oral Pathol Med. 2008 Sep;37(8):454-61. doi: 10.1111/j.1600-0714.2008.00661.x. Epub 2008 Mar 3.


Equine CD4(+) CD25(high) T cells exhibit regulatory activity by close contact and cytokine-dependent mechanisms in vitro.

Hamza E, Gerber V, Steinbach F, Marti E.

Immunology. 2011 Nov;134(3):292-304. doi: 10.1111/j.1365-2567.2011.03489.x.


Foxp3 regulates human natural CD4+CD25+ regulatory T-cell-mediated suppression of xenogeneic response.

Sun L, Yi S, O'Connell PJ.

Xenotransplantation. 2010 Mar-Apr;17(2):121-30. doi: 10.1111/j.1399-3089.2010.00571.x.


Increased sensitivity of CD4+ T-effector cells to CD4+CD25+ Treg suppression compensates for reduced Treg number in asymptomatic HIV-1 infection.

Thorborn G, Pomeroy L, Isohanni H, Perry M, Peters B, Vyakarnam A.

PLoS One. 2010 Feb 17;5(2):e9254. doi: 10.1371/journal.pone.0009254.


Functional defects and the influence of age on the frequency of CD4+ CD25+ T-cells in type 1 diabetes.

Brusko TM, Wasserfall CH, Clare-Salzler MJ, Schatz DA, Atkinson MA.

Diabetes. 2005 May;54(5):1407-14.


Expansion of human regulatory T-cells from patients with type 1 diabetes.

Putnam AL, Brusko TM, Lee MR, Liu W, Szot GL, Ghosh T, Atkinson MA, Bluestone JA.

Diabetes. 2009 Mar;58(3):652-62. doi: 10.2337/db08-1168. Epub 2008 Dec 15.


CD4+ Foxp3+ regulatory T cells suppress γδ T-cell effector functions in a model of T-cell-induced mucosal inflammation.

Yurchenko E, Levings MK, Piccirillo CA.

Eur J Immunol. 2011 Dec;41(12):3455-66. doi: 10.1002/eji.201141814. Epub 2011 Nov 10.


Clinical significance of increased CD4+CD25-Foxp3+ T cells in patients with new-onset systemic lupus erythematosus.

Zhang B, Zhang X, Tang FL, Zhu LP, Liu Y, Lipsky PE.

Ann Rheum Dis. 2008 Jul;67(7):1037-40. doi: 10.1136/ard.2007.083543. Epub 2008 Jan 16.


Dendritic cells partially abrogate the regulatory activity of CD4+CD25+ T cells present in the human peripheral blood.

Ahn JS, Krishnadas DK, Agrawal B.

Int Immunol. 2007 Mar;19(3):227-37. Epub 2007 Feb 7.


Forced overexpression of either of the two common human Foxp3 isoforms can induce regulatory T cells from CD4(+)CD25(-) cells.

Aarts-Riemens T, Emmelot ME, Verdonck LF, Mutis T.

Eur J Immunol. 2008 May;38(5):1381-90. doi: 10.1002/eji.200737590.


Idd9.1 locus controls the suppressive activity of FoxP3+CD4+CD25+ regulatory T-cells.

Yamanouchi J, Puertas MC, Verdaguer J, Lyons PA, Rainbow DB, Chamberlain G, Hunter KM, Peterson LB, Wicker LS, Santamaria P.

Diabetes. 2010 Jan;59(1):272-81. doi: 10.2337/db09-0648. Epub 2009 Oct 15.


Foxp3+CD25(high) CD4+ regulatory T cells from indeterminate patients with Chagas disease can suppress the effector cells and cytokines and reveal altered correlations with disease severity.

de Araújo FF, Corrêa-Oliveira R, Rocha MO, Chaves AT, Fiuza JA, Fares RC, Ferreira KS, Nunes MC, Keesen TS, Damasio MP, Teixeira-Carvalho A, Gomes JA.

Immunobiology. 2012 Aug;217(8):768-77. doi: 10.1016/j.imbio.2012.04.008. Epub 2012 May 9.


CD44 expression positively correlates with Foxp3 expression and suppressive function of CD4+ Treg cells.

Liu T, Soong L, Liu G, König R, Chopra AK.

Biol Direct. 2009 Oct 23;4:40. doi: 10.1186/1745-6150-4-40.


CD4(+) CD25(+) regulatory T cells ameliorate Behcet's disease-like symptoms in a mouse model.

Shim J, Lee ES, Park S, Bang D, Sohn S.

Cytotherapy. 2011 Aug;13(7):835-47. doi: 10.3109/14653249.2011.571245. Epub 2011 Apr 21.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk